EphA2-4B3-NOTA-64Cu

N/A

Report date: 2025/11/11 17:59:42

Base Information

Drug NameEphA2-4B3-NOTA-64Cu

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionEphrin type-A receptor 2 binders

TargetsEphrin type-A receptor 2

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Queensland

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Queensland

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A